Insulin Insulatard Nph Nordisk

   
Google
 
Web NewDrugInformation.com

Insulin Insulatard Nph Nordisk


Drug - Insulin Insulatard Nph Nordisk
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Insulin Susp Isophane Purified Pork
Multiple ingredients are in alphabetical order.

Strength - 100 UNITS/ML
The potency of the active ingredient(s), Insulin Susp Isophane Purified Pork. May repeat for multiple part products.

Applicant - NOVO NORDISK INC
The firm name holding legal responsibility for Insulin Insulatard Nph Nordisk. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018194
The FDA assigned number to Insulin Insulatard Nph Nordisk. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Insulin Insulatard Nph Nordisk. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Insulin Insulatard Nph Nordisk was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Insulin Insulatard Nph Nordisk. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Insulin Insulatard Nph Nordisk is in. Format is RX, OTC, DISCN.

Applicant Full Name - Novo Nordisk Inc
The full name of the firm holding legal responsibility for the new application of Insulin Insulatard Nph Nordisk.

Insulin Insulatard Nph Nordisk